4TULLOH R. Management and therapeutic option in pediatric puhnonary hypertenion [ J ]. Expert Rev Cardiovasc Ther, 2006,4 (3) :361 -374. 被引量：1
5Du JB,Li SZ,Wang BL,et al.Doppler echocardiographic evaluation of pulmonary artery pressure in pneumonia of infants and children.Pediatr Pulmonol,1991,10:296-298. 被引量：1
6Baquero H,Soliz A,Neira F,et al.Oral sildenafil in infants with persistent pulmonary hypertension of the newborn:a pilot randomized blinded study.Pediatrics,2006,117(4):1077-83. 被引量：1
7Farrow KN,Fliman P,Steinhorn RH.The diseases treated with ECMO:focus on PPHN.Semin Perinatol,2005,29(1):8-14. 被引量：1
8Hwang S J,Lee KH,Hwang JH,et al.Factors affecting the response to inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn infants.Yonsei Med J,2004 29,45(1):49-55. 被引量：1
9Benedict N, Seybert A, Mathier MA. Evidence - based pharmacological management of pulmonary arterial hypertension[ J]. Clin Ther,2007,29 (10) :2134 -2153. 被引量：1
10Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension [ J ]. J Am Coll Cardiol,2004,43 ( 12 ) : S5 - S12. 被引量：1
